The Turkevich method was optimized to prepare gold nanoparticles (AuNP) stabilized by polyethyleneglycol (PEG) for µCT. Using various independent modalities, we thoroughly characterized the optimized PEG-AuNPs. Here, we show that PEG-AuNPs are retained in the blood and provide a high contrast in the high-resolution µCT imaging of blood vessels and inner organs. The biodistribution is characterized by prolonged circulation in the blood and accumulation in the liver, spleen and skin. The accumulation of AuNP in the skin resulted in the blue discoloration of eyes and the whole skin. In vitro experiments using a leukemic monocyte THP-1 cell line model expressing high levels of NLRP3 demonstrated that the NLRP3inflammasome was not activated by PEG AuNP. Over 9 months, the mice were scanned by µCT and were in good health. Scans in mice using PEG-stabilized AuNPs in this study were sharper, with a higher contrast, when compared to a commercial contrasting agent at the same dose. The PEG-AuNPs were morphologically and chemically stable for at least two years when stored in the refrigerator.

• Klíčová slova
• biodistribution, gold nanoparticles, in vivo imaging, microcomputer tomography, nanotoxicology,
• Publikační typ
• časopisecké články MeSH

Gadolinium (Gd)-based contrast agents are extensively used for magnetic resonance imaging (MRI). Liposomes are potential nanocarrier-based biocompatible platforms for development of new generations of MRI diagnostics. Liposomes with Gd-complexes (Gd-lip) co-encapsulated with thrombolytic agents can serve both for imaging and treatment of various pathological states including stroke. In this study, we evaluated nanosafety of Gd-lip containing PE-DTPA chelating Gd+3 prepared by lipid film hydration method. We detected no cytotoxicity of Gd-lip in human liver cells including cancer HepG2, progenitor (non-differentiated) HepaRG, and differentiated HepaRG cells. Furthermore, no potential side effects of Gd-lip were found using a complex system including general biomarkers of toxicity, such as induction of early response genes, oxidative, heat shock and endoplasmic reticulum stress, DNA damage responses, induction of xenobiotic metabolizing enzymes, and changes in sphingolipid metabolism in differentiated HepaRG. Moreover, Gd-lip did not show pro-inflammatory effects, as assessed in an assay based on activation of inflammasome NLRP3 in a model of human macrophages, and release of eicosanoids from HepaRG cells. In conclusion, this in vitro study indicates potential in vivo safety of Gd-lip with respect to hepatotoxicity and immunopathology caused by inflammation.

• MeSH
• diethylentriaminpentaacetát gadolinia * škodlivé účinky   toxicita   MeSH
• fibrinolytika MeSH
• fosfatidylethanolaminy * škodlivé účinky   toxicita   MeSH
• hepatocyty účinky léků   MeSH
• inflamasomy MeSH
• kontrastní látky * MeSH
• kultivované buňky MeSH
• lidé MeSH
• liposomy * MeSH
• magnetická rezonanční tomografie * MeSH
• makrofágy účinky léků   MeSH
• nanočástice MeSH
• nosiče léků * MeSH
• protein NLRP3 MeSH
• Check Tag
• lidé MeSH
• Publikační typ
• časopisecké články MeSH
• práce podpořená grantem MeSH
• Názvy látek
• diethylentriaminpentaacetát gadolinia * MeSH
• fibrinolytika MeSH
• fosfatidylethanolaminy * MeSH
• gadolinium phosphatidylethanolamine-DTPA MeSH Prohlížeč
• inflamasomy MeSH
• kontrastní látky * MeSH
• liposomy * MeSH
• NLRP3 protein, human MeSH Prohlížeč
• nosiče léků * MeSH
• protein NLRP3 MeSH